Caplin Point Laboratories Limited (CAPLIPOINT.NS) NSE
1,988.10
-10.8(-0.54%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
1,988.10
-10.8(-0.54%)
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3406
First IPO Date
June 23, 2014
| Name | Title | Pay | Year Born |
| D. Muralidharan | Chief Financial Officer - Finance & Accounts | 5.4M | 1956 |
| Venkatram Ganapathisu Bramanian | General Counsel, Company Secretary & Compliance Officer | 5.4M | 1982 |
| Sridhar Ganesan | MD & Whole Time Director | 5.7M | 1955 |
| Neelakandan K. | President - API R&D - Hyderabad | 13.6M | 1981 |
| Sathya Narayanan | Deputy Chief Financial Officer | 0 | N/A |
| R. Dinesh | Functional Head - HO, Production Planning & Inventory Control | 0 | N/A |
| Sathish Krishnan | Vice President | 0 | 1978 |
| Sivakumar Balasubramanian | Plant Head - Puducherry | 0 | 1981 |
| S. Gunasakaran | President of Clinical Research Operations | 0 | N/A |
| Anto Vijinth V. | Functional Head -HO, HR & Admin | 0 | N/A |
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.